Imagine a patient who has fought hard to shrink a dangerous lung tumor. They receive powerful drugs, have surgery, and feel better. Then, four months later, new problems appear.
This happened to a 54-year-old man. He had locally advanced lung squamous cell carcinoma. Doctors treated him with chemotherapy and an immune checkpoint inhibitor called pembrolizumab. His tumor shrank significantly.
He then had surgery to remove the affected part of his lung. Afterward, he took just one drug to keep the cancer away. For four months, he seemed fine.
Then, his routine blood test showed something wrong. He started feeling tired. He had a low-grade fever. His lymph nodes under his arm swelled up.
Doctors found two very different diseases happening at the same time. This is extremely rare. One disease was therapy-related acute myeloid leukemia, or t-AML. The other was lymph node tuberculosis, or LNTB.
Lung cancer is common. But getting these two specific complications together is a medical mystery. Most people do not know that cancer treatment can sometimes lead to new blood cancers.
At the same time, tuberculosis is a global health issue. When a patient takes strong immune-boosting drugs, their body might not fight off a hidden TB infection.
This situation is frustrating for doctors. The symptoms look like the cancer coming back. But they are actually two new problems. If doctors miss the diagnosis, the patient could get very sick quickly.
The surprising shift
In the past, doctors might have thought the fever and fatigue meant the lung cancer had returned. They would have given more anti-cancer drugs. This would have made the leukemia worse and the tuberculosis worse.
But here is the twist. The real cause was the treatment itself. The chemotherapy drugs damaged the DNA in blood cells. This led to the leukemia.
The immune drugs changed the body's environment. This allowed the tuberculosis bacteria to grow in the lymph nodes. The body's defenses were too busy fighting the cancer to stop the infection.
Think of your immune system like a security team. They patrol your body to catch bad guys.
Chemotherapy is like a heavy storm. It knocks down the bad guys but also knocks down the security team. This creates a mess.
The leukemia starts because the storm damaged the DNA in the blood cell factories. These factories start making the wrong kind of cells.
The tuberculosis starts because the storm confused the security team. They could not find the TB bacteria hiding in the lymph nodes. The bacteria grew quietly until the patient got sick.
This report looks at one specific patient and reviews similar cases in medical literature. The patient was a 54-year-old man. He received four cycles of neoadjuvant therapy. This included carboplatin, paclitaxel, and pembrolizumab.
He had surgery to remove his right upper lung lobe. Then he took pembrolizumab for maintenance. Four months later, the symptoms started.
Doctors used bone marrow tests to find the leukemia. They used lymph node biopsies to find the tuberculosis. They also checked for specific gene mutations.
The patient had mutations in several genes. These include BRCA2, DNMT3A, IDH2, and KMT2A. These changes confirmed the leukemia diagnosis.
The lymph node tests confirmed the tuberculosis. The patient had a partial tandem duplication in the KMT2A gene. This is a specific genetic marker for this type of leukemia.
The treatment plan had to change fast. Doctors started a four-drug anti-tuberculosis regimen. They also started chemotherapy for the leukemia. This included venetoclax and azacitidine.
The patient achieved partial remission of the leukemia. He had no uncontrollable severe side effects. This shows that treating both diseases at once is possible.
This doesn't mean this treatment is available yet.
That is a critical point to remember. This is a case report. It describes one rare event. It does not mean every patient will get these diseases.
However, it teaches doctors to look closer. If a patient gets leukemia and TB after cancer treatment, they need special tests. A simple blood test is not enough.
Medical experts say this combination is a diagnostic challenge. The symptoms overlap. Fever, fatigue, and swollen nodes happen in many conditions.
Doctors must be careful. They need to rule out infection before assuming the cancer is back. They also need to check for new blood cancers after intense treatment.
This fits into the bigger picture of cancer care. As treatments get stronger, side effects can become more complex. We need to understand these risks better.
If you or a loved one is undergoing cancer treatment, talk to your doctor about side effects. Report new fevers or fatigue early.
Do not ignore swollen lymph nodes. They could be infection or something else.
Ask your doctor if you need a bone marrow test if symptoms do not improve. Early diagnosis is the key to successful treatment.
This study is based on a single case. That means we do not know how common this is in the general population.
The patient received a specific combination of drugs. Not every cancer patient gets this exact treatment.
We also do not know if this will happen with other drugs. More research is needed to understand the full risk.
Doctors will continue to study these rare complications. They want to find ways to prevent them.
Future trials might look at how to protect the immune system during treatment. They may also find better ways to spot these diseases early.
For now, the message is simple. Stay alert. Trust your medical team. Ask questions. Together, you can navigate these challenges safely.
